Document is current
Any future updates will be listed below
-
Authors
Ibáñez-Cabellos, José Santiago
Baviera-Muñoz, Raquel
Alemany-Perna, Berta
Sivera, Rafael
Bataller, Luis
Cesar, Sergio
González-Cabo, Pilar
García-Giménez, José Luis
Pallardó, Federico V.
Seco-Cervera, Marta
-
Funding
Funding for this research was provided by:
Federación de Ataxias de España (CONVOCATORIA DE AYUDAS A LA INVESTIGACIÓN)
Federación de Ataxias de España (CONVOCATORIA DE AYUDAS A LA INVESTIGACIÓN)
Instituto de Salud Carlos III (PI19/01084)
- License Information
-
More Information
Article History
Received: 3 February 2026
Accepted: 24 April 2026
First Online: 13 May 2026
Declarations
:
: Experimental protocols and methods were carried out after obtaining approval from the Biomedical Research Ethics Committee of HCUV (2022/173) and RVB (RVB21041ER) and it were conducted in accordance with the Declaration of Helsinki. All participants or their legal guardians provided written informed consent prior to inclusion.
: JLG-G and FVP are co-founders and owns shares of EpiDisease S.L., a Spin-Off of the Consortium Center for Biomedical Network Research of the ISCIII. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.
